Buffington Mohr McNeal’s Medtronic MDT Stock Holding History

Buffington Mohr McNeal’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-125	Closed	-$11K	–	243
2019 Q1	$11K	Buy	+125	New	+$11.2K	﹤0.01%	265

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Buffington Mohr McNeal's MDT Position: Q2 2019 in Review

Buffington Mohr McNeal sold out of Medtronic (MDT) in Q2 2019, closing a stake of 125 shares — an estimated $11K sold.

Buffington Mohr McNeal first reported a position in MDT in Q1 2019 and held it in 1 quarter. The position peaked at $11K in Q1 2019. 1,619 funds tracked by Wall St. Rank hold MDT as of Q2 2019.

Buffington Mohr McNeal reported no remaining Medtronic position as of Q2 2019 after selling out during the quarter.
Buffington Mohr McNeal sold 125 Medtronic shares in Q2 2019, an estimated $11K.
Buffington Mohr McNeal first reported a position in Medtronic in Q1 2019 and held it in 1 quarter.
Buffington Mohr McNeal's Medtronic position peaked at $11K in Q1 2019.
1,619 funds tracked by Wall St. Rank held Medtronic as of Q2 2019.

Based on Buffington Mohr McNeal's 13F filing for Q2 2019, filed 31 Jul 2019.